Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session
$AMAM
$API
$BILI
$BIVI
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Computer Software: Prepackaged Software
Technology
Gainers
- My Size, Inc. (NASDAQ:MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.
- Pharvaris N.V. (NASDAQ:PHVS) shares climbed 56.7% to $4.0914 after the company reported top-line Phase 2 data from the RAPIDe-1 study of PHVS416 for the on-demand treatment of HAE attacks. The primary endpoint and all secondary endpoints were met.
- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) gained 39.3% to $0.69. NYMOX recently announced new marketing submission for NYMOZARFEX for benign prostatic hyperplasia.
- Express, Inc. (NYSE:EXPR) gained 39% to $1.7807 after the company and WHP Global announced they have entered into a mutually transformative strategic partnership. WHP to invest $25 million to acquire 5.4 million newly issued shares of EXPR at $4.60 per share. Express reported a third-quarter FY22 sales decline of 8% year-on-year to $434.1 million
- Rent the Runway, Inc. (NASDAQ:RENT) shares rose 36.8% to $1.8609 after the company reported better-than-expected Q3 sales results. The company also raised its FY22 sales guidance above estimates.
- Hello Group Inc. (NASDAQ:MOMO) jumped 34.7% to $7.07 after the company reported better-than-expected Q3 results.
- Power REIT (NYSE:PW) gained 34.7% to $5.59.
- Gelesis Holdings, Inc. (NYSE:GLS) gained 25.8% to $0.4061.
- BioVie Inc. (NASDAQ:BIVI) rose 23% to $7.25.
- ZW Data Action Technologies Inc. (NASDAQ:CNET) jumped 21.6% to $0.7850. ZW Data Action Tech, last month, posted a Q3 loss of $0.08 per share.
- Agora, Inc. (NASDAQ:API) gained 19.9% to $3.7050.
- Cardlytics, Inc. (NASDAQ:CDLX) rose 19.5% to $4.97.
- Carvana Co. (NYSE:CVNA) jumped 19% to $4.5650. Recent reports indicated that some of the company's largest creditors have signed a pact to prevent a potential creditor fight.
- Entrada Therapeutics, Inc. (NASDAQ:TRDA) rose 18.5% to $21.00 after the company and Vertex Pharmaceuticals announced a collaboration to discover and develop Endosomal Escape Vehicle therapeutics for myotonic dystrophy type 1.
- Zhihu Inc. (NYSE:ZH) gained 18% to $1.5385.
- Ciena Corporation (NYSE:CIEN) shares gained 17% to $50.60 after the company reported better-than-expected Q4 sales results.
- Weibo Corporation (NASDAQ:WB) jumped 16.4% to $18.02.
- GDS Holdings Limited (NASDAQ:GDS) rose 15.3% to $20.27.
- iQIYI, Inc. (NASDAQ:IQ) gained 14.8% to $3.64.
- Lufax Holding Ltd (NYSE:LU) rose 14.8% to $2.2150.
- Kingsoft Cloud Holdings Limited (NASDAQ:KC) rose 14.8% to $3.42.
- Niu Technologies (NASDAQ:NIU) gained 14.8% to $5.29
- Tuniu Corporation (NASDAQ:TOUR) rose 14.5% to $2.02 after gaining over 20% on Wednesday. Tuniu recently posted a Q3 loss of $0.03 per share.
- HUYA Inc. (NYSE:HUYA) gained 14.1% to $2.9101.
- Qutoutiao Inc. (NASDAQ:QTT) rose 13.2% to $0.6050 after dropping 11% on Wednesday.
- Pennsylvania Real Estate Investment Trust (NYSE:PEI) gained 13.1% to $2.6018.
- Infinera Corporation (NASDAQ:INFN) gained 12.6% to $7.20. Infinera, last month, reported better-than-expected Q3 EPS and sales results..
- Melco Resorts & Entertainment Limited (NASDAQ:MLCO) rose 11.8% to $11.62.
- CarGurus, Inc. (NASDAQ:CARG) gained 11.6% to $13.32. CarGurus reported a $250 million share repurchase program.
- Datadog, Inc. (NASDAQ:DDOG) gained 9% to $74.35. Datadog Director Matthew Jacobson acquired a total of 192,154 shares an average price of $69.35.
- Bilibili Inc. (NASDAQ:BILI) rose 9% to $23.67 after gaining over 5% on Wednesday.
- HashiCorp, Inc. (NASDAQ:HCP) gained 8.3% to $28.94 after the company reported better-than-expected Q3 sales results. The company also issued Q4 and FY23 EPS and sales guidance above analyst estimates.
- Atlassian Corporation (NASDAQ:TEAM) jumped 7.8% to $135.29.
- Tencent Music Entertainment Group (NYSE:TME) gained 6.7% to $7.83. Morgan Stanley upgraded Tencent Music from Equal-Weight to Overweight and raised the price target from $4.5 to $8.5.
Losers
- Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) shares fell 71.6% to $1.0908 after the company announced topline primary Week 48 data from its Phase 3 D-LIVR study of lonafarnib in two regimens in patients with chronic Hepatitis Delta Virus (HDV).
- Relmada Therapeutics, Inc. (NASDAQ:RLMD) fell 49.5% to $2.10 after the company said the RELIANCE trial for REL-1017 did not meet the primary endpoint.
- Design Therapeutics, Inc. (NASDAQ:DSGN) fell 41.1% to $7.47 after the company reported data from its single-ascending dose trial of DT-216 for the treatment of Friedreich ataxia and portfolio progress.
- Context Therapeutics Inc. (NASDAQ:CNTX) dropped 27.7% to $1.0050 after the company reported preliminary Phase 2 data for ONA-XR metastatic breast cancer.
- TransCode Therapeutics, Inc. (NASDAQ:RNAZ) fell 19.4% to $0.7901. TransCode Therapeutics shares jumped 133% on Wednesday after the company announced withdrawal of the Registration Statement on Form S-1 filed on November 28, 2022 for a share offering for up to 12.5 million.
- Cano Health, Inc. (NYSE:CANO) dropped 18% to $1.3957 following a report suggesting Third Point has sold its stake in the company.
- Instil Bio, Inc. (NASDAQ:TIL) fell 18% to $1.00. Instil Bio announced plans to discontinue unmodified TIL programs including DELTA-1 and DELTA-2 trials of ITIL-168. The company will also reduce workforce by 60%.
- EBET, Inc. (NASDAQ:EBET) dropped 15.4% to $0.4490.
- Connexa Sports Technologies Inc. (NASDAQ:CNXA) declined 13% to $0.1717.
- Ambrx Biopharma Inc. (NYSE:AMAM) dropped 12.5% to $0.41.
- Cosmos Holdings Inc. (NASDAQ:COSM) shares fell 11.5% to $0.3990 after declining over 4% on Wednesday.
- Locafy Limited (NASDAQ:LCFY) fell 11.1% to $5.59 after dropping over 14% on Wednesday.
- Chart Industries, Inc. (NYSE:GTLS) dropped 10.8% to $120.29. Chart Industries reported proposed public offerings of $600 million of common stock and $300 million of depositary shares.
- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) dipped 10.1% to $0.2157.
- Mirati Therapeutics, Inc. (NASDAQ:MRTX) fell 9.1% to $45.06. JP Morgan and BMO Capital downgraded the stock.
- 17 Education & Technology Group Inc. (NASDAQ:YQ) shares fell 6.2% to $1.21. 17 Education & Technology posted a Q3 loss of $0.01 per share.
Also check this out Ethereum Moves Higher; Axie Infinity Becomes Top Loser.